(1) 1[The Standing Committee referred to in rule 60 shall consist of the following as its members:]
(i) The Drugs Controller of the Government of India ;
(ii) the Chief Chemist, Central Revenues Control Laboratory ;
(iii) one pharmacologist to be nominated by the Central Government ;
(iv) the Advise in Indigenous systems of Medicine, Ministry of Health, Family Planning and Urban Development:
2[Provided that the Drugs Controller, the Chief Chemist or the Adviser may, for reasons to be recorded by him in writing, depute the Deputy Drugs Controller, 3[Deputy Chief Chemist] the Deputy Advise in Indigenous System of Medicines, as the case may be, to attend any meeting of the Committee on his behalf.]
The Committee shall advise the Central Government on all matters connected with the technical aspects of the administration of the Act and their rules and, in particular, on the question whether-
(i) a particulars preparation is entitled to be treated, or to continue to be treated, as a genuine medicinal or toiler preparation for the purposes of the Act;
(ii) and if so, whether it should be treated, or continue to be treated, as a restricted or an unrestricted preparation.
(2) The Committee may tender such advice, on the motion of the Central Government and may make such investigation as it or the Central Government considers necessary, and the Central Government may take, on such advice, such decision as that Government thinks fit.
(3) For the purpose of such investigation, four samples of 227 ml. each or such other quantity of the preparation as may be considered necessary shall be taken.
26 4[(4) The Standing Committee shall before declaring under sub-rule (2) of rule 60 a preparation as restricted preparation, grant, if the person concerned so desires, an opportunity of being heard in the matter.
(5) Where a member of the Standing Committee is unable for any reason to, attend the meeting of that committee, he may nominate an officer subordinate to him attend the meeting on his behalf.]
CHAPTER V Warehousing